NO20076162L - Antitumoral tetrahydro-pyrimidiner - Google Patents

Antitumoral tetrahydro-pyrimidiner

Info

Publication number
NO20076162L
NO20076162L NO20076162A NO20076162A NO20076162L NO 20076162 L NO20076162 L NO 20076162L NO 20076162 A NO20076162 A NO 20076162A NO 20076162 A NO20076162 A NO 20076162A NO 20076162 L NO20076162 L NO 20076162L
Authority
NO
Norway
Prior art keywords
antitumoral
pyrimidines
tetrahydro
meandrites
meandrinidae
Prior art date
Application number
NO20076162A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Fernando Reyes Benitez
Maria Del Carmen Cue Marchante
David Montalvo Lobo
Ma Jesus Martin Lopez
Maria Cristina Mateo Urbano
Andres Francesch Solloso
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20076162L publication Critical patent/NO20076162L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20076162A 2005-05-03 2007-11-29 Antitumoral tetrahydro-pyrimidiner NO20076162L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05076037 2005-05-03
PCT/EP2006/004117 WO2006117197A1 (en) 2005-05-03 2006-05-03 Antitumoral tetrahydro-pyrimidines

Publications (1)

Publication Number Publication Date
NO20076162L true NO20076162L (no) 2007-11-29

Family

ID=36649783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076162A NO20076162L (no) 2005-05-03 2007-11-29 Antitumoral tetrahydro-pyrimidiner

Country Status (13)

Country Link
US (1) US20100216817A1 (ja)
EP (1) EP1879870A1 (ja)
JP (1) JP2008540362A (ja)
KR (1) KR20080007640A (ja)
CN (1) CN101171236A (ja)
AU (1) AU2006243407A1 (ja)
CA (1) CA2605784A1 (ja)
EA (1) EA013160B1 (ja)
IL (1) IL186781A0 (ja)
MX (1) MX2007013683A (ja)
NO (1) NO20076162L (ja)
NZ (1) NZ563054A (ja)
WO (1) WO2006117197A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210868A (zh) * 2011-04-29 2011-10-12 济南环肽医药科技有限公司 四氢嘧啶及其衍生物在制备口服吸收促进剂中的应用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN108120792B (zh) * 2017-12-14 2020-03-24 青海出入境检验检疫局检验检疫综合技术中心 一种四氢嘧啶的高效液相检测及含量测定方法
CN110156697B (zh) * 2019-05-30 2022-05-06 常州沃腾化工科技有限公司 一种1,2-二甲基-1,4,5,6-四氢嘧啶的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2743255A (en) * 1952-12-19 1956-04-24 Petrolite Corp Amine-modified thermoplastic phenolaldehyde resins and method of making same
US4292429A (en) * 1978-03-08 1981-09-29 Ciba-Geigy Corporation Imidazole urea and amido compounds

Also Published As

Publication number Publication date
NZ563054A (en) 2010-09-30
CN101171236A (zh) 2008-04-30
KR20080007640A (ko) 2008-01-22
US20100216817A1 (en) 2010-08-26
CA2605784A1 (en) 2006-11-09
EP1879870A1 (en) 2008-01-23
IL186781A0 (en) 2008-02-09
AU2006243407A1 (en) 2006-11-09
EA200702397A1 (ru) 2008-02-28
EA013160B1 (ru) 2010-02-26
WO2006117197A1 (en) 2006-11-09
MX2007013683A (es) 2007-12-03
JP2008540362A (ja) 2008-11-20

Similar Documents

Publication Publication Date Title
NO341663B1 (no) Cyklopropyl-kondenserte indolobenzaepin HCV NS5B inhibitorer
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
NO20081724L (no) Stabil farmasoytisk sammensetning omfattende et pyrimidin-sulfamid
NO20075616L (no) Tripeptider som hepatitt C virus inhibitorer
RS52534B (en) MACROCYCLIC COMPOUNDS OF HINOXALINE AS HCV NS3 PROTEASE INHIBITORS
EP1924593B8 (en) Hcv ns3 protease inhibitors
NO20092053L (no) HCV NS3-proteaseinhibitorer
EA200970478A1 (ru) Аналоги тиофена для лечения или предупреждения флавивирусных инфекций
TW200720285A (en) Nucleoside compounds for treating viral infections
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20091845L (no) Macrocykliske peptider som hepatitt C virus-inhibitorer
NO20070751L (no) Inhibitorer av HCV-replifikasjon
NO20091846L (no) Makrocykliske peptider som hepatitt C virus- inhibitorer
NZ596107A (en) Antiviral compounds and methods
NO20084645L (no) Cyklopropyl kondenserte indolobenzazepin HCV NS5B inhibitorer
EA200900676A1 (ru) Ингибиторы вируса гепатита с
PA8683501A1 (es) Derivados de isoquinolina
GT200600327A (es) Ciclohexilaminoisoquinolona
GB0521508D0 (en) Organic compounds
MY145788A (en) Antitumoral dihydropyran-2-one compounds
WO2007136817A3 (en) Substituted aryl piperidinylalkynyladenosines as a2ar agonists
WO2007017728A3 (en) Novel heterocyclic compounds
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application